RE: The choices facing Ariana11 Dec 2019 00:13
Evening all, tick up from me today on Stangerstill’s post and a lot of others recently, including yours John, because I think there is still much to debate.
I’m still going to play Devil’s Advocate on this as I still don’t see a straightforward path given the current options. Obviously, I have looked at the numbers, highlighted reasons why a JV on Salinbas is advantageous, how the company can mitigate the risks of having a partner with a controlling interest, but for me and, no doubt for everyone else, it comes down to a decision on whether they think the deal is right for Ariana and each shareholder’s investment - whether to vote for or against, whether to buy, hold or sell.
I agree that the proposed deal puts Ariana at a crossroads with two choices. The question I want to put is whether these are/should be the only two options? In other words, is this the best deal Ariana could get? Is it the only deal they will get? Or, is it a possibility that a better deal could be reached, either with the proposed partner or a new potential partner on Salinbas.
I would prefer Ariana to retain more of Red Rabbit with protection built into any agreement to ring fence it from the potential risks with Salinbas, but recognise that a JV agreement on Salinbas is the right way forward.
Ultimately, how much pressure is there to commit to a deal right now? If LOM at Kiziltepe can be extended for a further 10 years together with a similar LOM from Tavsan, is there any rush to accept the first deal that is put on the table?
Answers on a postcard.......
Cheers, Ash